Prevalence and risk factors of painful diabetic neuropathy: A systematic review and meta-analysis
Yong Tao, Haiyang Zhang, Claire MacGilchrist, Ellen Kirwan, Caroline McIntosh
Abstract
(OR = 1.62, 95 % CI, 1.43-1.83), longer diabetes duration (OR = 1.05, 95 % CI, 1.01-1.08), and nephropathy (OR = 1.32, 95 % CI, 1.24-1.40). Targeted screening and standardized diagnostic tools are urgently needed to enhance PDPN management and mitigate its burden globally.
Topics & Concepts
MedicineDiabetes mellitusMeta-analysisDiabetic neuropathyMEDLINEIntensive care medicineInternal medicineEndocrinologyPolitical scienceLawPain Mechanisms and TreatmentsBotulinum Toxin and Related Neurological DisordersNeurological Disorders and Treatments